demonstrated that YTHDF1 stabilizes E2F8 mRNA, which accelerates DNA damage repair and chemoresistance to adriamycin, cisplatin, and the PARP inhibitor olaparib in breast cancer cells (255). The gene discussed is YTHDF1; the disease is breast carcinoma.